Skip to main content
PLOS One logoLink to PLOS One
. 2023 Nov 30;18(11):e0295156. doi: 10.1371/journal.pone.0295156

Kinematic alteration in three-dimensional reaching movement in C3-4 level cervical myelopathy

Naoto Noguchi 1, Ryoto Akiyama 1,#, Ken Kondo 2,#, Duy Quoc Vo 3,‡, Lisa Sato 4, Akihito Yanai 5,‡, Masatake Ino 6, Bumsuk Lee 1,*
Editor: Nadinne Alexandra Roman7
PMCID: PMC10688652  PMID: 38032987

Abstract

Object

This study aimed to compare the reaching movement between two different spinal cord compression level groups in cervical myelopathy (CM) patients.

Methods

Nine CM patients with maximal cord compression at the C3-4 level (C3-4 group) and 15 CM patients with maximal cord compression at the C4-7 level (C4-7 group) participated in the study. We monitored three-dimensional (3D) reaching movement using an electronic-mechanical whack-a-mole-type task pre-and post-operatively. Movement time (MT) and 3D movement distance (MD) during the task were recorded. An analysis of variance for split-plot factorial design was performed to investigate the effects of compression level or surgery on MT and MD. Moreover, we investigated the relationship between these kinematic reaching parameters and conventional clinical tests.

Results

The 3D reaching trajectories of the C3-4 group was unstable with higher variability. The C3-4 group showed longer MT (p < 0.05) and MD (p < 0.01) compared with the C4-7 group both before and after surgery. Moreover, MT was negatively correlated with the Japanese Orthopedic Association score only in the C3-4 group (r = - 0.48).

Conclusion

We found that spinal cord compression at the C3-4 level had a negative effect on 3D reaching movement and the kinematic alteration influenced the upper extremity performance. This new knowledge may increase our understanding of kinematic alteration in patients with CM.

Introduction

Cervical myelopathy (CM) is a disorder caused by spinal cord compression associated with cervical spondylosis, disc herniation, and congenital stenosis [1]. CM patients generally suffer from sensory and motor symptoms such as paresthesia, muscle weakness, and clumsiness [2]. These impairments result in a decline in activities of daily living (ADLs) and quality of life [3]. In severe cases, cervical decompression surgery is necessary to relieve compression of the spinal cord.

Conventional clinical tests have been mainly focused on the distal arm dysfunction in CM. For example, the 10-s grip and release (G&R) test, which is one of the most commonly used clinical tests, is focused on the motor coordination between finger flexion and extension [4]. Similarly, CM symptoms tend to be characterized by impairments in hand dexterity such as loss of sensitivity, exaggerated deep tendon reflexes, and motor weakness [4,5]. However, pathophysiological studies on spinal cord compression identified that appearance of upper extremity symptoms depends on the level of spinal cord compression. Patients with C3-4 compression present proximal and distal arm weakness and sensory disturbances, whereas only distal arm dysfunction in patients with C6-7 level [6,7].

Previous studies suggested several possible reasons why proximal dysfunction in CM has not been adequately discussed compared to impairments in hand dexterity. First, the lower cervical spinal cord level is commonly affected in CM. Northover et al [8] reported that C5-6 level was the most severely and commonly affected level in patients, implying that distal arm dysfunction tends to occur more frequently compared to proximal dysfunction. Second, in multi-level cord compression distal arm dysfunction is easily perceived by the patients and clinicians [9]. Lastly, it is known that there are interneuronal systems which compensate for proximal arm dysfunction. In healthy individuals, propriospinal neurons (PN) at C3-4 level take the role of mediating corticomotoneuronal inputs and transmits proprioceptive feedback to control arm position during target reaching [10,11]. When damage occurs at C3-4 level, these feedforward and feedback control systems play a critical role in compensating decreased proximal arm function [12].

In addition to these pathophysiological aspects, we suppose that clinical tests for upper extremity function have inherent limitations in the assessment of the proximal arm function of CM patients. Clinical tests generally evaluate the reaching, grasping, and manipulation capability simultaneously, therefore it is difficult to separate proximal function from distal function. A fact worthy to note is that a discrepancy in reaching and grasping functions can be occurred in patients with CM. In order to solve this problem, several studies used an accelerometer to independently measure reaching function [13,14]. Although the sensor makes it possible to easily measure kinematic changes during reaching movement, data obtained from only one-axis acceleration (e.g., forward-backward direction) is still not enough to understand upper limb movement in three-dimensional (3D) space [13]. Recently, several techniques have been developed for synchronizing multiple accelerometers or combining three-axis acceleration data [14], but the necessity of a special calculation program and the time cost of data analysis limit its practical use in clinical environments. Therefore, the evaluation not depending on grasping or manipulation and detecting the changes in 3D reaching movements is necessary to accurately measure proximal arm function in CM.

The purpose of the study was to examine the sole reaching function in 3D space without being affected by distal function. In order to separate proximal from distal function, we used an electronic-whack-a-mole-type task which only requires shoulder and elbow joint movements, not accompanied by forearm or finger movements. We monitored the reaching movement time and distance during the task, suggesting that these parameters can detect the changes in any direction of reaching movement. We hypothesized that patients with C3-4 compression may have decreased reaching capability and the kinematic alteration has a negative influence on the upper extremity performance in CM patients.

Materials and methods

Participants

This prospective cross-sectional study was conducted from April 7, 2018 to November 29, 2020. Twenty-four CM patients who were waiting for cervical decompression surgery were recruited. Inclusion criteria were as follows: (1) performing pre-operative Magnetic resonance imaging (MRI), (2) having no visual disturbances or cognitive decline, (3) having no history of previous cervical spine surgery or other orthopedic disorders that may impair reaching movement, and (4) ability to walk with/without a walking aid. Participants were diagnosed with cervical spondylotic myelopathy (n = 22), ossification of the posterior longitudinal ligament (n = 1), or cervical spondylotic radiculopathy (n = 1). Handedness was evaluated with the Edinburgh Handedness Inventory, and all participants were right-handed.

The participants were classified into two subgroups, depending on the segmental level of maximal cord compression: a C3-4 group (maximal cord compression at C3-4 level, five men and four women, 74.3 ± 9.4 years), and a C4-7 group (maximal cord compression at C4-7 level, seven men and eight women, 65.2 ± 12.8 years). They underwent decompression surgery by laminoplasty (n = 17), laminectomy (n = 4), anterior spinal fusion (n = 2), or posterior spinal fusion (n = 1). Data from nine participants with lumbar stenosis (six men and three women, 62.0 ± 11.1 years) were collected for controls. Informed consent was obtained from all participants before the study. This study was approved by the Hospital Institutional Review Board (Approval number: 180101) and the University Ethical Review Board for Medical Research Involving Human Subjects (Approval numbers: HS2018-267 and HS2020-072).

Electronic-mechanical whack-a-mole-type task

Participants performed a task by standing in front of a height-adjustable table. An electronic-mechanical whack-a-mole-type task (K3000, Work Joy, Japan, 31.8 × 23.5 cm) was positioned at a 45-degree angle and 20 cm away from the participants (Fig 1A). Verbal instructions were given to tap the start icon with a wooden hand-held pen (1.5 cm in diameter and 21.5 cm long) and reach for 16 targets (3.5 cm in diameter) that appeared one by one on the screen (Fig 1B). The first target appeared on the screen when participants tapped the start icon, and the following target simultaneously appeared when the previous target was touched. The distance between the two paired targets ranged from 19.0 to 25.5 cm. Each participant performed two trials, and a 5-min rest was provided between trials. CM groups performed the task pre- (2.6 ± 1.8 days prior to operation) and post-operatively (18.0 ± 8.5 days after the operation), and the control group performed the task only postoperatively (35.2 ± 23.7 days after the operation).

Fig 1. Experimental apparatus.

Fig 1

(A) Electronic-mechanical whack-a-mole-type task: Participants use the wooden hand-held pen to reach and touch targets on the screen as accurately and quickly as possible. A Leap Motion Controller (LMC) was attached to the bottom of the screen and captured the three-dimensional position of the pen tip with a frequency of 128 Hz. (B) The sequence of target appearance: For example, when a participant touches “1”, a symmetrically located target (“5”) appears on the screen simultaneously. After touching “5”, another target appears randomly. If a “3” appears, the next target is always “7”, which is symmetrically located on the screen.

During the task, the position of the pen tip in 3D space was monitored using a Leap Motion Controller (LMC) with a frequency of 128 Hz in a spatial resolution of 0.7 mm [15]. The LMC consisted of three light-emitting diodes (LEDs) and two stereo cameras attached to the bottom of the screen. The cameras captured the reflection of the light, which the LEDs irradiated to the pen in an inverted pyramid 3D space (60 × 60 × 60 cm) during the task. Previous studies reported the reliability and validity of computer-stimulated movement tracking system using LMC for evaluating hand dexterity dysfunction in CM [16,17]. Based on the spatial and temporal information of the pen tip, we calculated two kinematic parameters as follows: (1) movement time (MT): the mean movement time of reaching between paired targets, and (2) 3D movement distance (MD): the mean trajectory distance of the pen tip between paired targets. In our previous study, the intra-subject repeatability of these parameters was assessed using intraclass correlation coefficients (ICC), and the parameters demonstrated substantial reliability (MT: ICC (1, 1) = 0.83 and MD: ICC (1, 1) = 0.60) [18].

Clinical tests

The latest version of the Japanese Orthopedic Association (JOA) score was used. The score consists of six domains: motor function in the upper extremities, motor function in the lower extremities, sensory function in the upper extremities, sensory function in the trunk, sensory function in the lower extremities, and bladder function. The minimum total score is 0 and the maximum is 17. In the present study, we only used the subscore of the upper extremities based on previous studies [2,19], and defined it as JOA-UEF [20]. The JOA-UEF was assessed from 0 to 4 points: 0 = unable to feed oneself with any tableware, including chopsticks, a spoon, or fork, and/or unable to fasten buttons of any size, 1 = can manage to feed oneself with a spoon and/or a fork but not with chopsticks, 2 = either chopstick feeding or writing is possible but not practical, and/or large buttons can be fastened, 3 = either chopstick feeding or writing is clumsy but practical, and/or cuff buttons can be fastened, and 4 = normal.

The maximum grip strength was measured with the Smedley Grip Tester (Gopher, Owatonna, MN, USA), and pulp pinch strength between thumb and index finger was measured with the JAMAR Hydraulic Pinch Gauge (Petterson Medical, Warrenville, IL, USA). The cutaneous pressure threshold of the central area of the thumb, index, and middle finger pulps were assessed with Touch Test Sensory Evaluators (North Coast Medical Inc., Morgan Hill, CA, USA), which apply standard calibrated forces of 0.07, 0.4, 2.0, 40, and 300 g. The lowest perceived monofilament is considered normal, and higher monofilament forces indicate severe sensory disturbance. In the 10-s G&R test, participants were asked to open and close their hands as quickly and fully as possible in 10 seconds. Hand dexterity function was evaluated by three subtests time (numbers 8, 9, and 10) of the Simple Test for Evaluating Hand Function (STEF) [21]. Total time of the three subtests was used for statistical analysis.

Statistical analysis

A one-way analysis of variance (ANOVA) was performed to compare demographic data and kinematic parameters among three groups. Tukey’s test was applied as a post hoc test to identify specific differences.

Secondly, a split-plot ANOVA was performed to investigate differences within CM groups. The factors were ‘compression level’ with two levels (maximal cord compression at C3-4 level and C4-7 level, and ‘surgery’ with two levels (pre- and post-operation).

Associations of the reaching parameters and other clinical tests with the JOA-UEF were examined in each CM group. Statistical analyses were performed using statistical software SPSS ver. 27.0 J for Windows (SPSS Japan., Tokyo, Japan). Values of p < 0.05 were considered significant.

Results

Fig 2 shows the 3D reaching trajectories during the task for representative patients. The control group patient moved between the targets in parabolic path with lower variability (Fig 2A). In contrast, the trajectory of the patient in C3-4 group was unstable with higher variability (Fig 2B).

Fig 2. The three-dimensional reaching trajectories during the task for representative patients.

Fig 2

The dots indicate the spatial position of the pen tip every 7.8ms, and the numbers indicate the location of targets on the screen. The control group patient moves between the targets in parabolic path with lower variability (Fig 2A). In contrast, the trajectory of the patient in C3-4 group was unstable with higher variability (Fig 2B).

Table 1 summarizes the demographic data and kinematic outcomes for the participants. Age, sex, body mass index, and disease duration were not different among the three groups. On the other hand, the one-way ANOVA and Tukey post-hoc analysis indicated that the C3-4 group required significantly longer MT (vs. control group; p < 0.05) and longer MD (vs. C4-7 group; p < 0.01).

Table 1. Demographic data and kinematic outcomes based on one-way ANOVA.

C3-4 (n = 9) C4-7 (n = 15) Control (n = 9)
Demographic
 Age (years) 74.3 ± 9.4 65.2 ± 12.8 62.0 ± 11.1
 Sex (male/female) 5 / 4 7 / 8 6 / 3
 BMI (kg/m2) 26.3 ± 3.5 23.4 ± 3.4 25.4 ± 4.4
 Disease duration (months) 27.4 ± 53.7 27.9 ± 25.2 30.9 ± 23.7
Reaching movement
 Movement time (s) a 0.83 ± 0.13 0.69 ± 0.17 0.63 ± 0.06
 Movement distance (m) b 0.27 ± 0.03 0.24 ± 0.02 0.26 ± 0.03

BMI, body mass index.

Tukey’s test.

a Significant difference between C3-4 and control groups (p < 0.05).

b Significant difference between C3-4 and C4-7 groups (p < 0.01).

Table 2 shows the results of the comparisons within CM groups. A split-plot ANOVA revealed the significant main effect of compression level in MT (p = 0.02), MD (p < 0.01), and JOA-UEF score (p = 0.04), indicating deficits in reaching function and the upper extremity performance in the C3-4 group. The main effect of surgery was found in the JOA-UEF score (p < 0.01) and the G&R test (p < 0.01), suggesting that upper extremity performance and finger coordination improved postoperatively in both CM groups. A synergistic interaction was found in the JOA-UEF score (p < 0.01).

Table 2. Effects of compression level or surgery based on ANOVA for split-plot factorial design.

C3-4 (n = 9) C4-7 (n = 15) Compression level effect Surgical effect Interaction
Pre-ope Post-ope Pre-ope Post-ope F value P value F value P value F value P value
Reaching movement
 Movement time (s) 0.83 ± 0.13 0.75 ± 0.13 0.69 ± 0.17 0.65 ± 0.10 5.84 0.02 4.06 0.06 0.54 0.47
 Movement distance (m) 0.27 ± 0.03 0.26 ± 0.03 0.24 ± 0.02 0.24 ± 0.01 12.29 < 0.01 1.00 0.33 1.93 0.18
JOA-UEF 2.22 ± 0.97 4.00 ± 0.00 3.13 ± 0.74 3.93 ± 0.26 4.77 0.04 58.92 < 0.01 8.48 < 0.01
Grip strength (kg) 22.33 ± 10.31 23.78 ± 9.72 25.82 ± 10.50 24.20 ± 12.26 0.20 0.66 < 0.01 0.95 1.18 0.29
Pinch strength (kg) 3.62 ± 1.69 3.62 ± 1.34 4.06 ± 1.87 3.79 ± 1.36 0.22 0.64 0.56 0.46 0.61 0.44
Cutaneous pressure threshold (g)
 Thumb 5.30 ± 13.04 0.43 ± 0.61 23.09 ± 77.28 0.18 ± 0.16 0.45 0.51 1.12 0.30 0.47 0.50
 Index finger 5.08 ± 13.12 0.39 ± 0.62 20.41 ± 77.35 0.22 ± 0.50 0.33 0.57 0.90 0.35 0.35 0.56
 Middle finger 5.22 ± 13.07 0.22 ± 0.17 23.05 ± 77.29 0.35 ± 0.68 0.47 0.50 1.12 0.30 0.46 0.51
10-s G&R test (number) 15.44 ± 6.82 19.67 ± 6.25 18.29 ± 5.25 22.14 ± 6.16 1.34 0.26 11.75 < 0.01 0.02 0.88
STEF (s) 48.23 ± 18.51 40.05 ± 5.11 39.66 ± 12.31 41.83 ± 28.00 0.27 0.61 0.37 0.55 1.09 0.31

JOA, Japanese Orthopedic Association; UEF, upper extremity function; G&R, grip and release; STEF, Simple Test for Evaluating Hand Function.

Values in bold indicate significant difference.

The results of the correlations between the JOA-UEF score and the other tests are shown in Table 3. In the C3-4 group, the JOA-UEF score was associated with MT (r = - 0.48, p = 0.04), the G&R test (r = 0.57, p = 0.02), and the STEF time (r = - 0.57, p = 0.01). In the C4-7 group, the JOA-UEF score was correlated with the cutaneous pressure threshold of the fingers (thumb: r = - 0.41, p = 0.02; index: r = - 0.43, p = 0.02; middle: r = - 0.48, p < 0.01), and the G&R test (r = 0.52, p < 0.01).

Table 3. Correlations between the reaching movement and upper extremity functional tests in each cervical myelopathy group.

JOA-UEF
C3-4 C4-7
r P value r P value
Reaching movement
 Movement time (s) - 0.48 0.04 - 0.23 0.23
 Movement distance (m) - 0.45 0.06 0.16 0.39
Grip strength (kg) 0.27 0.27 - 0.10 0.60
Pinch strength (kg) 0.13 0.61 0.10 0.59
Cutaneous pressure threshold (g)
 Thumb - 0.28 0.26 - 0.41 0.02
 Index finger - 0.28 0.26 - 0.43 0.02
 Middle finger - 0.29 0.25 - 0.48 < 0.01
10-s G&R test (number) 0.57 0.02 0.52 < 0.01
STEF (s) - 0.57 0.01 - 0.10 0.62

n = 48 (24 individuals × 2 time points).

Values in bold indicate significant correlation.

Discussion

We found that spinal cord compression at the C3-4 level had a negative effect on reaching movement. Moreover, the correlation between MT and the JOA-UEF was only found in the C3-4 group, implying cord compression at the C3-4 level has a critical influence on the upper extremity performance.

The key finding in the present study is that the alteration of reaching movement was found in C3-4 level myelopathy (Tables 1 and 2). Although reaching movement in CM patients has been assessed, the influence of compression level was not adequately discussed. To the best of our knowledge, our study is the first report to reveal that the alteration of reaching movement may differ depending on the compression level. This finding can be explained by the methodological uniqueness of our experimental technique. It is known that the inability to extend fingers and grip/release rapidly is one of the most common hand dysfunction in CM patients [4]. However, previous studies used pointing movement to a target with the extended index finger [12] or reach-to-grasp movement [2]. We hypothesized reaching movement can be affected by distal function, and introduced the technique not accompanying the movement of distal joints. As a result, the alteration of reaching movement in C3-4 level myelopathy was found. Thus, it is reasonable to assume that separation of proximal function from distal is critical to know the influence of compression level on proximal upper extremity function in CM patients.

Another reason for the finding of the compression level-dependent difference could be related to the higher level of task difficulty in our experiment. We assume that single-directional reaching movement in a horizontal plane, which has been typically used in many studies in CM [2,12] is too easy to identify compression level-dependent difference. Target direction and height of reaching movement affect reaching performance. For example, MT in the lateral target is significantly longer than in the medial target, even though the distance is equal [22]. Endpoint error increases when reaching a high place compared to low-reaching movement [23]. In addition, the unpredictability of target positions also can be related to the difficulty of the task. During the whack-a-mole-type task in our experiment, the following target simultaneously and pseudo-randomly appeared when the previous target was touched. This does not allow our participants to prepare a precise control of target reaching. The influence is consistent with a previous study that reported increased MT and MD when reaching a target shifting unexpectedly [24]. Taken together, we suggest that the high level task incorporating unpredictable multidirectional reaching conditions could be useful for obtaining more detailed information on the proximal upper limb dysfunction in CM.

In C3-4 group, the JOA-UEF was associated with distal motor function, but not with distal sensory function (Table 3). Before the experiment, based on the idea that CM symptoms typically occur at and below the compression level, we expected that the JOA-UEF may correlate with both proximal and distal arm sensorimotor function in C3-4 group. As expected, MT and G&R test were associated with the JOA-UEF, implying the critical relationship between proximal/distal limb motor function and daily performance. On the other hand, interestingly, distal sensory function was not related with daily performance. The discrepancy between distal motor and sensory functions in C3-4 group could be explained by a pathophysiological model of CM. The model suggests that CM symptom progression can be divided into three subgroups depending on the progress of myelopathy [25]. First, gray matter in the central section of spinal cord is damaged, and motor and sensory dysfunction occur at the compression level (Type Ⅰ). Then, pyramidal tract lesion occurs, and as a result motor dysfunction appears below the compression level is added (Type Ⅱ). Lastly, the lesion extends to spinothalamic pathway, which leads below level sensory dysfunction (Type Ⅲ). When we interpret our finding based on this pathophysiological classification, it is reasonable to assume that the influence of motor and sensory functions on daily performance can be changed in accordance with the progress in CM.

Although both the JOA-UEF and the STEF evaluate upper limb performance in CM, the surgical effect was only found in the JOA-UEF score (Table 2). This implies that the upper extremity function was improved only in the practical use in eating or dressing, but not in the ability to rapidly carry objects. One potential reason may be a sequence of stepwise recovery in the motor function. In patients with stroke, for example, the appearance of voluntary movement always precedes the ability to produce fast moments [26]. They can first grasp and release objects slowly with their paretic hand. Movements that require speed are always obtained in the last recovery stage. A similar stepwise sequence can be found in tendon injury or burn in the hand and upper extremity [27,28]. Indeed, a previous CM study reported that the JOA-UEF score improved 1 week after surgery, on the other hand, the postoperative improvement in the STEF required 1 month [19]. Monitoring both practical use in daily living and maximal capacity is, therefore, necessary for understanding the longitudinal recovery process in upper extremity performance in CM.

Several limitations of the present study should be acknowledged. Firstly, we only analyzed the total time and distance required reaching movement between targets. It was reported that multiple peak velocities are detected in a single reaching movement in patients with sensorimotor impairment [29]. Additional kinetic parameters analyzing more detailed temporal/spatial changes need be considered to identify which phase during target reaching was affected by spinal cord compression. Secondly, we did not consider a capability of static standing balance during the reaching task. It would be possible that the postural adjustment was an uncontrolled factor in this study. Simultaneous measurement with displacement trajectory using a force platform may clarify the dynamic interaction between the reaching and balance strategies.

In conclusion, this study demonstrated that spinal cord compression at the C3-4 level had a negative effect on reaching movement, and alteration in reaching movement was correlated with the severity of upper extremity performance. This new knowledge may increase our understanding of kinematic alteration in CM patients.

Supporting information

S1 File. Data set.

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

Our study was supported by JSPS KAKENHI under Grant number 21K17507. Moreover, the funders had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Mattei TA, Goulart CR, Milano JB, Dutra LPF, Fasset DR. Cervical spondylotic myelopathy: pathophysiology, diagnosis, and surgical techniques. ISRN Neurol. 2011; 463729. doi: 10.5402/2011/463729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Omori M, Shibuya S, Nakajima T, Endoh T, Suzuki S, Irie S, et al. Hand Dexterity Impairment in Patients with Cervical Myelopathy: A New Quantitative Assessment Using a Natural Prehension Movement. Behav Neurol. 2018; 4: 5138234. doi: 10.1155/2018/5138234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhang RJ, Shen CL, Zhang JX, Zhang XJ, Dong FL, Tao H, et al. Clinical features and surgical outcomes of cervical spondylotic myelopathy in patients of different ages: a retrospective study. Spinal Cord. 2018; 56(1): 7–13. doi: 10.1038/sc.2017.91 [DOI] [PubMed] [Google Scholar]
  • 4.Ono K, Ebara S, Fuji T, Yonenobu K, Fujiwara K, Yamashita K. Myelopathy hand. New clinical signs of cervical cord damage. J Bone Joint Surg Br. 1987; 69: 215–219. doi: 10.1302/0301-620X.69B2.3818752 [DOI] [PubMed] [Google Scholar]
  • 5.Akutagawa T, Tani T, Kida K, Tadokoro N, Enoki H, Nagano Y, et al. A new method for characterizing hand dysfunction in cervical spondylotic myelopathy: a preliminary study. Spinal Cord. 2016; 54(3): 221–225. doi: 10.1038/sc.2015.123 [DOI] [PubMed] [Google Scholar]
  • 6.Seichi A, Takeshita K, Kawaguchi H, Matsudaira K, Higashikawa A, Ogata N, et al. Neurologic level diagnosis of cervical stenotic myelopathy. Spine (Phila Pa 1976). 2006; 31(12): 1338–1343. doi: 10.1097/01.brs.0000219475.21126.6b [DOI] [PubMed] [Google Scholar]
  • 7.Matsumoto M, Ishikawa M, Ishii K, Nishizawa T, Maruiwa H, Nakamura M, et al. Usefulness of neurological examination for diagnosis of the affected level in patients with cervical compressive myelopathy: prospective comparative study with radiological evaluation. J Neurosurg Spine. 2005; 2(5): 535–539. doi: 10.3171/spi.2005.2.5.0535 [DOI] [PubMed] [Google Scholar]
  • 8.Northover JR, Wild JB, Braybrooke J, Blanco J. The epidemiology of cervical spondylotic myelopathy. Skeletal Radiol. 2012; 41(12): 1543–1546. doi: 10.1007/s00256-012-1388-3 [DOI] [PubMed] [Google Scholar]
  • 9.Houten JK, Cooper PR. Laminectomy and posterior cervical plating for multilevel cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament: effects on cervical alignment, spinal cord compression, and neurological outcome. Neurosurgery. 2003; 52(5): 1081–1087. doi: 10.1227/01.NEU.0000057746.74779.55 [DOI] [PubMed] [Google Scholar]
  • 10.Roberts LV, Stinear CM, Lewis GN, Byblow WD. Task-dependent modulation of propriospinal inputs to human shoulder. J Neurophysiol. 2008; 100(4): 2109–2114. doi: 10.1152/jn.90786.2008 [DOI] [PubMed] [Google Scholar]
  • 11.Pierrot-Deseilligny E. Propriospinal transmission of part of the corticospinal excitation in humans. Muscle Nerve. 2002; 26(2): 155–172. doi: 10.1002/mus.1240 [DOI] [PubMed] [Google Scholar]
  • 12.Igarashi K, Shibuya S, Sano H, Takahashi M, Satomi K, Ohki Y. Functional assessment of proximal arm muscles by target-reaching movements in patients with cervical myelopathy. Spine J. 2011; 11(4): 270–280. doi: 10.1016/j.spinee.2011.02.003 [DOI] [PubMed] [Google Scholar]
  • 13.Noguchi N, Lee B, Kondo K, Ino M, Kamiya S, Yamazaki T. Changes in reaching skill in patients with cervical spondylosis after cervical decompression surgery. J Phys Ther Sci. 2019; 31(10): 760–764. doi: 10.1589/jpts.31.760 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Amici C, Ragni F, Ghidoni M, Fausti D, Bissolotti L, Tiboni M. Multi-Sensor Validation Approach of an End-Effector-Based Robot for the Rehabilitation of the Upper and Lower Limb. Electronics. 2020; 9: 1751. doi: 10.3390/electronics9111751 [DOI] [Google Scholar]
  • 15.Weichert F, Bachmann D, Rudak B, Fisseler D. Analysis of the accuracy and robustness of the leap motion controller. Sensors (Basel). 2013; 13(5): 6380–6393. doi: 10.3390/s130506380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Alagha MA, Alagha MA, Dunstan E, Sperwer O, Timmins KA, Boszczyk BM. Development of a new assessment tool for cervical myelopathy using hand-tracking sensor: Part 1: validity and reliability. Eur Spine J. 2017; 26(4): 1291–1297. doi: 10.1007/s00586-017-4948-3 [DOI] [PubMed] [Google Scholar]
  • 17.Alagha MA, Alagha MA, Dunstan E, Sperwer O, Timmins KA, Boszczyk BM. Development of a new assessment tool for cervical myelopathy using hand-tracking sensor: Part 2: normative values. Eur Spine J. 2017; 26(4): 1298–1304. doi: 10.1007/s00586-017-4949-2 [DOI] [PubMed] [Google Scholar]
  • 18.Oguchi T, Odagaki M, Noguchi N, Kondo K, Akiyama R, Lee B. Comparison of Reaching Motion between Elderly and Young adults Using an Electronic Evaluation System of Upper Extremity Function (in Japanese with English abstract). IEEJ Transactions on Electronics, Information and Systems. 2022; 142: 563–568. doi: 10.1541/ieejeiss.142.563 [DOI] [Google Scholar]
  • 19.Fujiwara H, Makino T, Yonenobu K, Honda H, Kaito T. Correlations and time-dependent changes of upper arm performance tests, the Japanese Orthopaedic Association score, and a newly developed patient-based outcome measure: the Japanese Orthopaedic Cervical Myelopathy Questionnaire. Bone Joint J. 2016; 98-B(7): 990–996. doi: 10.1302/0301-620X.98B7.37055 [DOI] [PubMed] [Google Scholar]
  • 20.Noguchi N, Lee B, Kamiya S, Kondo K, Teshima R, Ino M, et al. Grip force control during object manipulation in cervical myelopathy. Spinal Cord. 2020; 58(6): 689–694. doi: 10.1038/s41393-020-0414-x [DOI] [PubMed] [Google Scholar]
  • 21.Shindo K, Oba H, Hara J, Ito M, Hotta F, Liu M. Psychometric properties of the simple test for evaluating hand function in patients with stroke. Brain Inj. 2015; 29(6): 772–776. doi: 10.3109/02699052.2015.1004740 [DOI] [PubMed] [Google Scholar]
  • 22.Mani S, Mutha PK, Przybyla A, Haaland KY, Good DC, Sainburg RL. Contralesional motor deficits after unilateral stroke reflect hemisphere-specific control mechanisms. Brain. 2013; 136(Pt 4): 1288–1303. doi: 10.1093/brain/aws283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wagner JM, Rhodes JA, Patten C. Reproducibility and minimal detectable change of three-dimensional kinematic analysis of reaching tasks in people with hemiparesis after stroke. Phys Ther. 2008; 88(5): 652–663. doi: 10.2522/ptj.20070255 [DOI] [PubMed] [Google Scholar]
  • 24.Krüger M, Hermsdörfer J. Target Uncertainty During Motor Decision-Making: The Time Course of Movement Variability Reveals the Effect of Different Sources of Uncertainty on the Control of Reaching Movements. Front Psychol. 2019; 28:10:41. doi: 10.3389/fpsyg.2019.00041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hattori S, Oyama M, Hayakawa H, Kawai S, Saiki K, Shigematsu A. Pathology and classification of Cervical myelopathy (in Japanese). Rinsho Seikeigeka. 1975; 10: 990–998. doi: 10.11477/mf.1408905269 [DOI] [Google Scholar]
  • 26.Crow JL, Harmeling-van der Wel BC. Hierarchical properties of the motor function sections of the Fugl-Meyer assessment scale for people after stroke: a retrospective study. Phys Ther. 2008; 88(12): 1554–1567. doi: 10.2522/ptj.20070186 [DOI] [PubMed] [Google Scholar]
  • 27.Howell JW, Peck F. Rehabilitation of flexor and extensor tendon injuries in the hand: current updates. Injury. 2013; 44(3): 397–402. doi: 10.1016/j.injury.2013.01.022 [DOI] [PubMed] [Google Scholar]
  • 28.Cowan AC, Stegink-Jansen CW. Rehabilitation of hand burn injuries: current updates. Injury. 2013; 44(3): 391–396. doi: 10.1016/j.injury.2013.01.015 [DOI] [PubMed] [Google Scholar]
  • 29.Sarlegna FR, Gauthier GM, Bourdin C, Vercher Jean-Louis, Blouin J. Internally driven control of reaching movements: A study on a proprioceptively deafferented subject. Brain Res Bull. 2006; 69(4): 404–415. doi: 10.1016/j.brainresbull.2006.02.005 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Nadinne Alexandra Roman

18 Oct 2023

PONE-D-23-26285Kinematic alteration in three-dimensional reaching movement in C3-4 level cervical myelopathyPLOS ONE

Dear Dr. Lee,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: 

The decision for the manuscript entitled "Kinematic alteration in three-dimensional reaching movement in C3-4 level cervical myelopathy" PONE-D-23-26285, is to perform minor adjustments as requested by one of the reviewers. Pleas find the comment below ( in section 5 Review Comments to the Author).

==============================

Please submit your revised manuscript by Dec 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nadinne Alexandra Roman, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. Thank you for stating the following financial disclosure:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

6. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors performed a study addressing “Kinematic alteration in three-dimensional reaching movement in C3-4 level cervical myelopathy”. However, there is one unclear area. Why is it appropriate to monitor 3D reaching movement and measure movement time (MT) and 3D movement distance (MD) during the task to have the objectives of this study achieved? Is it difficult to do so by other methods? Please describe your reasons in more detail.

Reviewer #2: The article title was so intresting to me , that made me to read all the article ,

You can move foreward and , do some future researches after this study to conplete your study on whole spine ,

Thanks

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Nov 30;18(11):e0295156. doi: 10.1371/journal.pone.0295156.r002

Author response to Decision Letter 0


26 Oct 2023

Thank you very much for your suggestions and comments. We found your suggestions and comments were very helpful in improving our manuscript. In a rebuttal letter, we summarized specific responses to all instructions from the Academic Editor and queries raised by the reviewers.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Nadinne Alexandra Roman

16 Nov 2023

Kinematic alteration in three-dimensional reaching movement in C3-4 level cervical myelopathy

PONE-D-23-26285R1

Dear Dr. Lee,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nadinne Alexandra Roman, Ph.D.

Academic Editor

PLOS ONE

Acceptance letter

Nadinne Alexandra Roman

20 Nov 2023

PONE-D-23-26285R1

Kinematic alteration in three-dimensional reaching movement in C3-4 level cervical myelopathy

Dear Dr. Lee:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nadinne Alexandra Roman

Academic Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES